SOMERSET, N.J., Feb. 13, 2018 -- MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of proprietary, cloud-based electronic health records, practice management and mHealth solutions, is pleased to announce its partnership with Pikeville Medical Center (“Pikeville”), an MTBC client, as a key event sponsor for the hospital’s annual East Kentucky Heart Ball.
A. Hadi Chaudhry, MTBC’s President, stated, “Our relationship with Pikeville, which began in 2016, continues to grow day-by-day. We’re thrilled to again be part of this fantastic event and support Pikeville’s initiative to provide top quality healthcare services as they serve their community.”
Pikeville, a member of the Mayo Clinic Care Network, has been dedicated to providing quality care to patients in Kentucky for almost a century. It operates a 300-bed facility that provides more than 400 services, including every major specialty and most subspecialties, and employs more than 3,000 employees and approximately 400 credentialed providers. MediGain Practice Management, an MTBC subsidiary, has provided end-to-end revenue cycle management services to Pikeville since October 2016.
Pikeville’s recent East Kentucky Heart Ball brought together more than 500 members of the community to benefit Pikeville’s premier Heart and Vascular Institute. Attendees included patients, and leaders from the medical, business and political communities.
About MTBC
MTBC is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers. Our integrated Software-as-a-Service (or SaaS) platform helps our customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. MTBC’s common stock trades on the NASDAQ Capital Market under the ticker symbol “MTBC,” and its Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol “MTBCP.”
For additional information, please visit our website at www.mtbc.com.
Follow MTBC on Twitter, LinkedIn and Facebook.
Disclaimer:
This press release is for information purposes only, and does not constitute an offer to sell or solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.
SOURCE MTBC
Investor and Company Contact: Bill Korn Chief Financial Officer Medical Transcription Billing, Corp. [email protected] 732-873-5133


ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains
FTC Questions Apple News Over Alleged Bias Against Conservative Media
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
Bank of America CEO Brian Moynihan’s 2025 Compensation Rises 17% to $41 Million Amid Strong Profit Growth
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
Lockheed Martin Secures $101M in U.S. Defense Contracts for AEGIS, F-35, and Missile Systems
Grok AI Market Share Surges as xAI Faces Scrutiny Over Image Generation Controversy
Paramount Skydance Appoints Rene Augustine as SVP of Global Public Policy Amid Warner Bros Takeover Battle
Michael Kors Marks 45 Years at New York Fashion Week with Fall/Winter Collection Showcase
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
Westpac (ASX: WBC) Q1 Profit Rises 6% as Lending Growth and Treasury Income Strengthen Earnings
Anduril Eyes $60 Billion Valuation in New Funding Round to Expand Defense Manufacturing and Autonomous Fighter Jet Development 



